BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31608783)

  • 1. T cell subtypes and its therapeutic potential in autoimmune diseases and cancer.
    Awasthi A; Kumar H
    Int Rev Immunol; 2019; 38(5):181-182. PubMed ID: 31608783
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting T cell metabolism for therapy.
    O'Sullivan D; Pearce EL
    Trends Immunol; 2015 Feb; 36(2):71-80. PubMed ID: 25601541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.
    Palmer DC; Restifo NP
    Trends Immunol; 2009 Dec; 30(12):592-602. PubMed ID: 19879803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive immunotherapy for cancer.
    Ruella M; Kalos M
    Immunol Rev; 2014 Jan; 257(1):14-38. PubMed ID: 24329787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application.
    Gomes AQ; Martins DS; Silva-Santos B
    Cancer Res; 2010 Dec; 70(24):10024-7. PubMed ID: 21159627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Regensburg Center for Interventional Immunology (RCI) symposium on "Synthetic immunology and environment-adapted redirection of T cells", 17-18 July, 2019, Regensburg, Germany.
    Beckhove P; Edinger M; Feuerer M; Gattinoni L; Abken H
    Cancer Immunol Immunother; 2020 Apr; 69(4):677-682. PubMed ID: 32123937
    [No Abstract]   [Full Text] [Related]  

  • 7. Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy.
    Wang W; He Y; Wu S
    Future Oncol; 2018 Oct; 14(24):2433-2436. PubMed ID: 30141349
    [No Abstract]   [Full Text] [Related]  

  • 8. Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.
    Watt WC; Cecil DL; Disis ML
    Semin Immunopathol; 2017 Apr; 39(3):245-253. PubMed ID: 27975138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune cells for immunotherapy of autoimmune and cancer disorders.
    Schäfer C; Ascui G; Ribeiro CH; López M; Prados-Rosales R; González PA; Bueno SM; Riedel CA; Baena A; Kalergis AM; Carreño LJ
    Int Rev Immunol; 2017 Nov; 36(6):315-337. PubMed ID: 28933579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy: Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies.
    Daniyan AF; Brentjens RJ
    Nat Rev Clin Oncol; 2017 Jun; 14(6):333-334. PubMed ID: 28397826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKT cells: potential targets for autoimmune disease therapy?
    Hammond KJ; Godfrey DI
    Tissue Antigens; 2002 May; 59(5):353-63. PubMed ID: 12144618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
    Paul S; Lal G
    Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding lymphocyte metabolism for use in cancer immunotherapy.
    MacPherson S; Kilgour M; Lum JJ
    FEBS J; 2018 Jul; 285(14):2567-2578. PubMed ID: 29611301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of memory T cell subsets for adoptive immunotherapy.
    Busch DH; Fräßle SP; Sommermeyer D; Buchholz VR; Riddell SR
    Semin Immunol; 2016 Feb; 28(1):28-34. PubMed ID: 26976826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells erase bad memory.
    Kurts C
    Eur J Immunol; 2010 Jul; 40(7):1870-2. PubMed ID: 20549670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy for cancer: building on success.
    Gattinoni L; Powell DJ; Rosenberg SA; Restifo NP
    Nat Rev Immunol; 2006 May; 6(5):383-93. PubMed ID: 16622476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer T cells and rheumatoid arthritis: friend or foe?
    Elewaut D
    Arthritis Res Ther; 2005; 7(2):88-9. PubMed ID: 15743495
    [No Abstract]   [Full Text] [Related]  

  • 18. In this issue: Antibodies and T Cell subtypes in diseases and therapy.
    Kumar H; Bot A
    Int Rev Immunol; 2018; 37(4):175-176. PubMed ID: 30239264
    [No Abstract]   [Full Text] [Related]  

  • 19. T cells take aim at cancer.
    Pardoll D
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15840-2. PubMed ID: 12461164
    [No Abstract]   [Full Text] [Related]  

  • 20. Fine tuning subsets of CD4
    Zhao Z; Zhang X; Su L; Xu L; Zheng Y; Sun J
    Int Immunopharmacol; 2018 Mar; 56():269-276. PubMed ID: 29414661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.